NCT05673798View on ClinicalTrials.gov

Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients

CompletedOBSERVATIONAL
Enrollment

569

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Small Cell Lung Cancer
Interventions
OTHER

initial chemotherapy response

Initial chemotherapy response is the first imaging examination of SCLC patient after starting chemotherapy

All Listed Sponsors
lead

The Second Hospital of Shandong University

OTHER

NCT05673798 - Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients | Biotech Hunter | Biotech Hunter